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Background: Obesity is associated with the development of Insulin
resistance (IR) and the metabolic syndrome (MS). However, it is still
unknown whether the stage of life that obesity has developed offers
a risk regardless of the individual's adiposity level in adulthood.
Objective: To evaluate the association between MS, obesity onset and
the TG / HDL-c ratio in women with severe obesity and to establish
cutoff points for the TG/HDL-c ratio considering the obesity onset.
Methods: Forty-seven women with severe obesity who will undergo
bariatric surgery were evaluated. Anthropometric and metabolic
parameters were measured and the HOMA-IR and the TG / HDL-c
ratio were calculated. The volunteers were grouped according
obesity onset. The Receiver Operating Characteristic (ROC) was
explored and built to define cutoff points for TG/HDL-C fractions as
predictors of MS. Results: The prevalence of women with MS was
76,59%. Most of the sample (63.8%) reported having started obesity
in adulthood. Women who developed obesity during infancy/
adolescence had higher weight (p=0.008), body mass index
(p=0.031), and hip circumference (p=0.036) compared to those
who developed in adulthood; however, no association was found
between obesity onset with SM. The TG/HDL-C cutoff points
established for those who developed early and late obesity were
2.30 and 2.19, respectively. Conclusion: The life phase of obesity
development was not related with MS, however, women with a
diagnosis of early obesity had higher anthropometric markers of
adiposity. The TG/HDL-c ratio might be useful as a predictor of MS
according to the early or late development of obesity.
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Abstract
Introduction: COVID-19 pandemic has forced healthcare system to
organize the healthcare delivery differently. Methodology: We
conducted a retrospective analysis of the Diabetes Wellness Care
(DWC) database to understand implications of new virtual clinic
model initiated through telemedicine which was extended to
manage COVID-19 patients (n=218) Results: 17% of COVID-19
patients were known cases of Type 2 Diabetes (n=37). In these
subset of patients, typical COVID-19 pneumonia was present in 45%
(n= 17) with 35% (n= 6) requiring hospitalization. COPD/ bronchial
asthma pre-existed in 14.5% (n=31) of patients with 3 patients
required hospitalization and of which one patient was a known case
of diabetes. 11% (n=23) were known hypertensives of which one
patient required hospitalization, with coexisting diabetes. 5.5%
(n=12) had Coronary Artery Disease and none required
hospitalization. 6 patients had concomitant renal impairment.
Patients were under strict recommendations to monitor blood
glucose and BP by SMBG and Home-Based Blood Pressure Monitoring
(HBPM). Doxycycline and ivermectin were prescribed. Azithromycin
was added if cough or sore throat was present. Favipiravir was
prescribed if elevated CRP and IL-6 with concomitant fever. Pulse
oximeter to measure SpO2 was convenient and clinically meaningful
during home isolation. X- Ray chest or HRCT scan of chest was
mandated including elderly N 60 years. LMWH was utilized only in 2
cases in home isolation (with high D Dimer). 8 patients required
hospitalization. Conclusion: Our telemedicine approach enabled a
prompt detection of the symptoms, which enabled an effective triage
and led to isolation of infectious patients
Keywords: Telemedicine, COVID-19, Comorbidities, Diabetes,
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Abstract
Background. Serum 25-hydroxy-vitamin D deficiency is related to
metabolic diseases as polycystic ovary syndrome, obesity, insulin
resistance, cardiovascular diseases, cancer, gestational diabetesmellitus
(GDM). Objective: To evaluate the effect of vitamin D therapy on
metabolic parameters in pregnant women. Methods: There was a 16-
week study of 62 participants with gestational diabetes mellitus. All
pregnant women followed an appropriate diet and physical activity.
Management of 37 women included 2,000 IU/day of cholecalciferol per
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os. Body mass index (BMI), hemoglobin A1c (HbA1c), fasting plasma
glucose (FPG), plasma 25- (OH) vitamin D, low‐density lipoprotein
cholesterol (LDL‐C), homeostatic model assessment of insulin
resistance (HOMA-ir) were estimated in pregnant women with GDM
before and after the 16-week period. Quantitative data are expressed as
the mean ± SD. The correlation between variables was assessed using
the Pearson correlation coefficient. P-value b0.05 was considered
statistically significant. All information was processed with SPSS 21.0.
Results: The mean BMI was (30,2±2,34) kg/m2, baseline serum 25-
(OH) vitamin D levels in all women were in a deficient limit (less than
30 nmol/L). HOMA in both groups was more than 3. The mean LDL‐C
was (3,3±0,63) mmol/l and didn`t differ in the two groups. 25-(OH)
vitamin D levels were inversely associated with BMI (r=–0.4; P=0.05),
HOMA (r=–0.6; P=0.005), LDL‐C (r=–0.3; P=0.04). Vitamin D
therapy has had significant improvement in plasma LDL‐C
concentration, HbA1c, FPG in women with GDM (Pb0.05). Compared
with the Ist group cholecalciferol therapy had lead to a reduction of
HOMA in the IInd group by (2,3±0,94) in 4 months (P b 0.05).
Conclusions. The daily intake of vitamin D was accompanied by the
significant glycemic improvement and themajority of women achieved
diabetes control without insulin injections. Strong inverse correlation
between 25 (OH) vitamin D levels and HOMA, reduction of HOMA can
indicate improved sensitivity to insulin and benefits of vitamin D
supplementation for themanagement of insulin resistance in GDMwith
vitamin D insufficiency.
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Background: Epidemiological and animal studies show diabetes-
induced fetal programming can lead to adverse complications in the
late-life of offspring. Western society consumes more calorie-rich foods
every day. Objective: In order to understand the association between
the influence of a hyperglycemic intrauterine environment and the
consumption of a high-fat diet after weaning, this studywas carried out
with laboratory animals to reproduce the conditions of our current
society. Methods: Adult Sprague Dawley rats from mothers with mild
diabetes werematedwith healthymales to obtain offspring. The female
pups (2/mother) were fed a standard (OD/SD, n=9 rats) or high-fat
(OD/HFD, n=12 rats) diet from weaning up to adulthood. At four
months old, the oral glucose tolerance test (OGTT) was carried out
before pregnancy and confirmed glucose intolerance status in both
groups. Following, the rats were submitted to cesarean section to
evaluate maternal reproductive and fetal development outcomes.
Pb0.05 was considered for statistically significant difference. Results:
At the end of pregnancy, the OD/HFD rats presented a higher
percentage of embryo losses, lower number of corpora lutea, alive
fetuses, and implantation. The placental and fetal weights were
reduced, and the newborns were classified as small for gestational age
compared toOD/SD, contributing to the lower litterweight. Conclusion:
Ourfindings suggest the consumption of a post-weaning high-fat diet in
association to maternal diabetes influence cause a glucose intolerance
at the adulthood of the female offspring and exacerbate impaired
reproductive repercussions and fetal development to the next
generation.
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Abstract
Type 1 diabetes mellitus (DM1) is an autoimmune disease characterized
by the destruction of insulin-producing pancreatic β cells. Among the
current experimental therapies, we highlight the use of
transdifferentiated mesenchymal stromal cells (MSCs) into insulin-
producing cells (IPCs). Here, we studied the strategy of implanting IPCs
differentiated from adipose tissue MSCs in the subcutaneous region (SC)
of rats to investigate their protection against hyperglycemia induced by
streptozotocin. The first phase of this study (in vitro)was to characterize
adipose-derived stromal cells (ADSCs) and to evaluate the protocol for
their differentiation in IPCs. The second phase was to assess the
functionality of IPCs in vivo three and eight weeks after implant. The
cells were then implanted in SC after one-week DM1 model induction
(Process: 30626). The implant improved hyperglycemia and reduced the
serum content of advanced glycation end products (AGEs) in diabetic
rats at three weeks, but this effect was not observed after the longer
period of eight weeks, showing a transient effect. Serum C-peptide was
not detected in the SC group, neither after three nor eight weeks of DM1
model. Regarding animal body weight, both diabetic and implanted rats
maintained their weight over time, while the Sham group presented the
natural increase related to the normal growth of the animal. Together,
these data are promising but also need improvement in the effectiveness
of the therapy, with future studies attempting implantation of a larger
number of cells or multiple implants, since the subcutaneous access is
not very invasive and easy to perform.
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